Clindamycin–primaquine for pneumocystis jiroveci pneumonia in renal transplant patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s15010-014-0660-y.pdf
Reference32 articles.
1. Martin SI, Fishman JA. Pneumocystis pneumonia in solid organ transplant recipients. Am J Transpl. 2009;9(Suppl 4):S227–33.
2. Neff RT, Jindal RM, Yoo DY, Hurst FP, Agodoa LY, Abbott KC. Analysis of USRDS: incidence and risk factors for pneumocystis jiroveci pneumonia. Transplantation. 2009;88:135–41.
3. Goto N, Oka S. Pneumocystis jirovecii pneumonia in kidney transplantation. Transpl Infect Dis. 2011;13:551–8.
4. Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350:2487–98.
5. Huang L, Morris A, Limper AH, Beck JM. An official ATS workshop summary: recent advances and future directions in pneumocystis pneumonia (PCP); ATS pneumocystis workshop participants. Proc Am Thorac Soc. 2006;3:655–64.
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital;BMC Infectious Diseases;2024-01-31
2. Pneumocystis jirovecii Pneumonia after Heart Transplantation: Two Case Reports and a Review of the Literature;Pathogens;2023-10-21
3. The regimen based on trimethoprim/sulfamethoxazole combination of caspofungin and corticosteroids as the first-line therapy for non-HIV patients with severe pneumocystis jirovecii pneumonia：a retrospective research of a tertiary hospital;2023-08-31
4. Preliminary Study on the Combination Effect of Clindamycin and Low Dose Trimethoprim-Sulfamethoxazole on Severe Pneumocystis Pneumonia After Renal Transplantation;Frontiers in Medicine;2022-05-06
5. Fungal pneumonia in kidney transplant recipients;Respiratory Medicine;2021-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3